• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Lung Infections May Hamper Efficacy of FDG-PET

Article

A new retrospective study published in JAMA identified that tuberculosis and certain fungal infections in the lungs could hamper the efficient detection of lung cancer by FDG-PET imaging.

A test used to diagnose lung cancer may not be as reliable in geographic regions where certain lung infections are more common, a new analysis says.

One noninvasive way of detecting lung cancer is through the use of what's known as functional imaging. For lung cancer, a specific type of functional imaging called FDG-PET is used, according to the study authors.

Cancerous tumors generally look different on FDG-PET images than do parts of the lungs that don't have cancer, according to background information in the study. But, it can be difficult to tell the difference between lung cancer and some lung infections, according to the study.

Lung conditions that might affect the accuracy of the functional imaging tests include tuberculosis and fungal infections, the study authors said.

Geographic regions in the new analysis where tuberculosis is common include China, Japan and South Africa. Areas where fungal lung infections occur frequently include the Mississippi, Missouri and Ohio river valley regions, as well as the U.S. Southwest, and Ontario, Canada, according to the analysis.

The analysis looked at the results of 70 studies.

Report on MedlinePlus: http://1.usa.gov/Yc90VQ

Related Videos
Mila Felder, MD, FACEP, emergency physician and vice president for Well-Being for All Teammates, Advocate Health
Shawn Tuma, JD, CIPP/US, cybersecurity and data privacy attorney, Spencer Fane LLP
Judith Alberto, MHA, RPh, BCOP, director of clinical initiatives, Community Oncology Alliance
Mila Felder, MD, FACEP, emergency physician and vice president for Well-Being for All Teammates, Advocate Health
Will Shapiro, vice president of data science, Flatiron Health
Mila Felder, MD, FACEP, emergency physician and vice president for Well-Being for All Teammates, Advocate Health
Mila Felder, MD, FACEP, emergency physician and vice president for Well-Being for All Teammates, Advocate Health
Will Shapiro, vice president of data science, Flatiron Health
Jonathan E. Levitt, Esq, Frier Levitt, LLC
Judy Alberto, MHA, RPh, BCOP, Community Oncology Alliance
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.